MAP2K7 and hepatocellular carcinoma: Emerging evidence demostrates that decreased LDLR expression in cancer cells impairs LDL uptake but promotes HCC cell proliferation and metastasis in vivo and in vitro, potentially via the activation of the MEK/ERK signaling pathway to enhance de novo cholesterol synthesis [36].